Your session is about to expire
← Back to Search
Compass Course for Breast Cancer Survivors (CC-V Trial)
N/A
Waitlist Available
Led By Mary V Radomski, OTR/L, PhD
Research Sponsored by Mary Radomski
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up through study completion (about 4 months)
Awards & highlights
CC-V Trial Summary
This trial will test whether the Compass Course, a group intervention for individuals with breast cancer, is feasible and efficacious when delivered over Zoom.
Eligible Conditions
- Breast Cancer
CC-V Trial Timeline
Screening ~ 3 weeks3 visits
Treatment ~ Varies
Follow Up ~ through study completion (about 4 months)
Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~through study completion (about 4 months)
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.Primary outcome measures
Change in Engagement in Meaningful Activities survey
Change in Meaning in Life Questionnaire
Change in Purpose Status Question
+1 moreSecondary outcome measures
Change in Beck Depression Inventory -- II
Change in State-Trait Anxiety Inventory
CC-V Trial Design
1Treatment groups
Experimental Treatment
Group I: Compass CourseExperimental Treatment1 Intervention
Virtual Compass Course
Find a Location
Who is running the clinical trial?
Mary RadomskiLead Sponsor
2 Previous Clinical Trials
348 Total Patients Enrolled
1 Trials studying Breast Cancer
300 Patients Enrolled for Breast Cancer
Mary V Radomski, OTR/L, PhDPrincipal InvestigatorSenior Scientific Advisor
1 Previous Clinical Trials
48 Total Patients Enrolled
Media Library
Eligibility Criteria:
This trial includes the following eligibility criteria:- You have a past history of brain injury or stroke that may make it difficult for you to learn.You can see, hear, and speak on your own or with the help of devices.You have a physical or mental condition that makes it difficult to do everyday tasks.
Research Study Groups:
This trial has the following groups:- Group 1: Compass Course
Awards:
This trial has 1 awards, including:- No Placebo-Only Group - All patients enrolled in this study will receive some form of active treatment.
Timeline:
This trial has the following timeline:- Screening: It may take up to 3 Weeks to process to see if you qualify in this trial.
- Treatment: The duration you will receive the treatment varies.
- Follow Ups: You may be asked to continue sharing information regarding the trial for 6 Months after you stop receiving the treatment.
Frequently Asked Questions
These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.
Are there still opportunities for individuals to join this clinical experiment?
"According to the information on clinicaltrials.gov, this medical trial is not presently enrolling patients - despite having been first posted on March 1st 2021 and last modified on June 6th 2022. However, there are 2602 alternate studies actively recruiting new participants at this time."
Answered by AI
Share this study with friends
Copy Link
Messenger